AMRUTANJAN HEALTH CARE
|
|
BOM : 590006     NSE : AMRUTANJAN     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
May 29,2023 |
Price(EOD): βΉ 599.05
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 1,749.23 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
AMRUTANJAN HEALTH CARE | -0.2% | -0.6% | -28.6% |
SUN PHARMACEUTICAL INDUSTRIES | 4% | -1.1% | 6.6% |
DIVIS LABORATORIES | 2.8% | 7.5% | -4.1% |
CIPLA | 2.7% | 4.6% | -2% |
DR REDDYS LABORATORIES | 2.2% | -7.4% | 4.1% |
TORRENT PHARMACEUTICALS | 0.8% | 4.6% | 31.3% |
ABBOTT INDIA | 1.8% | -1.2% | 20.3% |
ZYDUS LIFESCIENCES | 1% | -0.6% | 37.9% |
ALKEM LABORATORIES | 2.9% | -2.4% | 14.1% |
FUNDAMENTAL ANALYSIS OF AMRUTANJAN HEALTH CARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF AMRUTANJAN HEALTH CARE
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
41.85
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 41.85 Cr
[Latest Qtr - Dec2022 - Standalone Results ] 6.62
P/B Calculated based on Book Value of Rs 264.52 Cr
[Latest Year - Mar2022 - Standalone Results ] 4.54
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2022 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
71% 67% 76% |
SHARE PRICE MOMENTUM OF AMRUTANJAN HEALTH CARE
AMRUTANJAN HEALTH CARE vs SENSEX
DEBT OF AMRUTANJAN HEALTH CARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0 - |
- - - - |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF AMRUTANJAN HEALTH CARE
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF AMRUTANJAN HEALTH CARE
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-11.81% -23.68% -16.74% -16.08% |
-11.79% -52.56% -48.04% -47.95% |
QtrlyTrend |
-8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
AMRUTANJAN HEALTH CARE related INDICES
You may also like the below Video Courses
FAQ about AMRUTANJAN HEALTH CARE
Is AMRUTANJAN HEALTH CARE good for long term investment?
As on May 29,2023, the Fundamentals of AMRUTANJAN HEALTH CARE look Strong and hence it may be good for long term investment! See Financial Performance of AMRUTANJAN HEALTH CARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is AMRUTANJAN HEALTH CARE UnderValued or OverValued?
As on May 29,2023, AMRUTANJAN HEALTH CARE is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of AMRUTANJAN HEALTH CARE ?
As on May 29,2023, the Intrinsic Value of AMRUTANJAN HEALTH CARE is Rs. 351.30 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 351.30
Fair Value [Median EV / Sales Model] : Rs. 357.87
Fair Value [Median Price / Sales Model] : Rs. 341.12
Estimated Median Fair Value of AMRUTANJAN HEALTH CARE : Rs. 351.30
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is AMRUTANJAN HEALTH CARE trading at a Premium or Discount?
As on May 29,2023, AMRUTANJAN HEALTH CARE is trading at a Premium of 71% based on the estimates of Median Intrinsic Value!